Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Resokine

Next Previous
Search
Drug Profile

Resokine

Alternative Names: aTyr 1920; HisRSN4 - aTyr Pharma; Histidyl-tRNA synthetase - aTyr Pharma; HRS (1-60) - aTyr Pharma; Resected-tRNA synthetase - aTyr Pharma; Resokine IV; Truncated-tRNA synthetase - aTyr Pharma

Latest Information Update: 08 Mar 2016

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator aTyr Pharma
  • Class Amino acids peptides and proteins; Amino acyl-tRNA synthetases; Aminoacyltransferases; Biological proteins; Proteins
  • Mechanism of Action Histidine-tRNA ligase modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Immunological disorders; Inflammatory bowel diseases

Most Recent Events

  • 21 May 2014 Adverse events data from a phase I trial in Immunological disorders released by aTyr
  • 21 May 2014 aTyr completes a phase I trial in Immunological disorders in European Union
  • 24 Feb 2014 Phase-I clinical trials in Immunological disorders (in volunteers) in European Union (IV)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top